Efficacy of Jelly Fig (Ficus Awkeotsang Makino) Extract for Atopic Dermatitis
NCT ID: NCT07113366
Last Updated: 2025-08-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
30 participants
INTERVENTIONAL
2024-05-01
2024-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Efficacy of Patients With Moderate to Severe Atopic Dermatitis Treated With Chinese Herbal Medicine
NCT04686955
Topical NF-kappaB Decoy in the Treatment of Atopic Dermatitis
NCT00125333
Indigo Naturalis in Treating Atopic Dermatitis Topically
NCT02669888
A Phase II, Placebo-controlled Trial Evaluating the Efficacy of Antroquinonol in Patients With Atopic Dermatitis
NCT04110873
Effects of a Mixed Chinese Herbal Formula on Atopic Dermatitis
NCT05455060
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High-dose FAE cream (5.0 mg/mL)
Ficus awkeotsang Makino extract (FAE)
FAE cream
Ficus awkeotsang Makino extract (FAE)
Low- dose FAE cream (1.0 mg/mL)
Ficus awkeotsang Makino extract (FAE)
FAE cream
Ficus awkeotsang Makino extract (FAE)
Placebo
Placebo
Placebo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
FAE cream
Ficus awkeotsang Makino extract (FAE)
Placebo
Placebo
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Clinical diagnosis of atopic dermatitis (AD) according to the Hanifin and Rajka criteria
* Investigator's Global Assessment (IGA) score of 2 (mild) or 3 (moderate) at screening
Exclusion Criteria
* Use of phototherapy, systemic corticosteroids, or other systemic immunosuppressants within 28 days before baseline
* Use of topical corticosteroids (TCS) or topical calcineurin inhibitors (TCI) within 14 days before baseline
* Presence of active skin infections
* Pregnancy or breastfeeding
* Known hypersensitivity to any component of the investigational product
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kaohsiung Veterans General Hospital.
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Chiau-Sheng Jang
Department of Dermatology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kaohsiung Veterans General Hospital
Kaohsiung City, Kaohsiung, Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KSVGH24-CT3-31
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.